Table 3.
Groups | Zone of inhibition in different concentration (mm) |
|||
---|---|---|---|---|
25 µl | 50 µl | 75 µl | 100 µl | |
Authentic Phenazine | 18.8 ± 0.07 | 19.5 ± 0.10 | 23.8 ± 0.07 | 24.8 ± 0.07 |
Carbendazim | 18.3 ± 0.08 | 19.6 ± 0.10 | 23.1 ± 0.09 | 23.8 ± 0.07 |
VSMKU1 | 20.0 ± 0.06 | 21.8 ± 0.07 | 24.0 ± 0.06 | 25.6 ± 0.05 |
VSMKU3 | 16.0 ± 0.06 | 17.0 ± 0.06 | 18.3 ± 0.08 | 20.0 ± 0.08 |
VSMKU4 | 15.5 ± 0.08 | 16.6 ± 0.05 | 20.8 ± 0.07 | 21.3 ± 0.08 |
VSMKU5 | 14.1 ± 0.07 | 17.0 ± 0.06 | 17.6 ± 0.05 | 19.3 ± 0.08 |
VSMKU6 | 13.0 ± 0.06 | 14.6 ± 0.05 | 16.3 ± 0.08 | 20.1 ± 0.07 |
VSMKU7 | 16.8 ± 0.07 | 18.3 ± 0.08 | 20.1 ± 0.07 | 23.1 ± 0.07 |
VSMKU8 | 16.3 ± 0.07 | 18.5 ± 0.08 | 21.5 ± 0.07 | 23.1 ± 0.07 |
VSMKU17 | 15.3 ± 0.08 | 17.3 ± 0.08 | 19.6 ± 0.10 | 21.5 ± 0.08 |
VSMKU18 | 16.5 ± 0.08 | 18.3 ± 0.08 | 20.5 ± 0.08 | 23.0 ± 0.06 |
VSMKU19 | 16.1 ± 0.07 | 17.8 ± 0.07 | 19.5 ± 0.08 | 21.8 ± 0.07 |
VSMKU20 | 13.3 ± 0.08 | 15.5 ± 0.08 | 18.8 ± 0.06 | 20.0 ± 0.06 |
VSMKU23 | 14.5 ± 0.08 | 15.5 ± 0.08 | 17.0 ± 0.06 | 20.1 ± 0.07 |
VSMKU27 | 16.3 ± 0.10 | 18.0 ± 0.06 | 19.0 ± 0.06 | 22.0 ± 0.06 |
VSMKU28 | 17.0 ± 0.06 | 19.0 ± 0.06 | 20.6 ± 0.08 | 22.1 ± 0.07 |
VSMKU30 | 16.0 ± 0.06 | 18.0 ± 0.06 | 19.0 ± 0.06 | 21.5 ± 0.08 |
VSMKU31 | 14.0 ± 0.06 | 16.0 ± 0.06 | 18.0 ± 0.06 | 20.0 ± 0.06 |
VSMKU34 | 12.0 ± 0.06 | 12.5 ± 0.08 | 15.0 ± 0.06 | 17.0 ± 0.06 |
Two way ANOVA | ||||
LSD (P = 0.05) | ||||
Concentration | 0.032 (***) | |||
Isolates/groups, | 0.073 (***) | |||
Interaction effect (concentration of filtrate × isolates) | ** |